IL6 and Alzheimer disease: Therefore, noninvasive (auricular) vagal nerve stimulation is discussed as a therapeutic strategy for AD as well as severe COVID-19, since a downregulation of inflammatory pathways (reduction of IL-6 levels) is expected as a result [127].